{"version":"1.0","type":"link","title":"Central Nervous System Progression in Patients Receiving ALK-Targeted Central Nervous System-Penetrable Tyrosine Kinase Inhibitors: Treatment Patterns and Outcomes.","author_name":"Singhal S 외","author_url":"https://prs-insight.online/author/Singhal%20S","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/100954","thumbnail_width":1200,"thumbnail_height":630}